Stockscreener 앱 받기
0.00
100.00%
-2.05
전일 마감가:
$2.05
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$116.14M
수익:
$1.50M
순이익/손실:
$-64.59M
주가수익비율:
0.00
EPS:
-1.67
순현금흐름:
$-55.17M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$2.54
립 테라퓨틱스 Stock (LPTX) Company Profile
명칭
Leap Therapeutics Inc
전화
617 252 4343
주소
47 THORNDIKE STREET, CAMBRIDGE, MA
Compare LPTX vs VRTX, REGN, ALNY, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LPTX
Leap Therapeutics Inc
|
0.00 | 116.14M | 1.50M | -64.59M | -55.17M | -1.67 |
VRTX
Vertex Pharmaceuticals Inc
|
454.00 | 115.33B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
732.87 | 77.48B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
312.17 | 41.40B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
663.93 | 41.09B | 4.16B | 1.29B | 734.26M | 19.59 |
ONC
Beone Medicines Ltd Adr
|
275.28 | 30.56B | 5.36B | 287.73M | 924.18M | 2.5229 |
립 테라퓨틱스 Stock (LPTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-01-29 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2021-10-04 | 개시 | Mizuho | Buy |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2020-06-29 | 개시 | Piper Sandler | Overweight |
| 2020-02-11 | 개시 | Robert W. Baird | Outperform |
| 2019-11-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-09-13 | 재개 | Raymond James | Outperform |
| 2017-03-07 | 개시 | Ladenburg Thalmann | Buy |
모두보기
립 테라퓨틱스 주식(LPTX)의 최신 뉴스
Published on: 2026-03-19 01:39:58 - baoquankhu1.vn
Can Leap Therapeutics Inc stock outperform in a bear marketWeekly Profit Recap & Fast Moving Trade Plans - baoquankhu1.vn
Leap Therapeutics (LPTX) Stock Price, News & Analysis $LPTX - MarketBeat
Leap Therapeutics (NASDAQ:LPTX) Trading Up 368.6% – Still a Buy? - Defense World
Cypherpunk Technologies Inc. (Formerly Leap Therapeutics) Combines Digital Privacy Tech and Cancer Drug Development – 2025 Annual Report Overview - Minichart
LPTX SEC FilingsLeap Therapeutic 10-K, 10-Q, 8-K Forms - Stock Titan
Leap Therapeutics, Inc. Common Stock (CYPH) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Leap Therapeutics, Inc.Common Stock (NQ: LPTX - The Chronicle-Journal
Downgrade Watch: What is ONTOs TAM Total Addressable Market2025 Analyst Calls & Weekly Setup with High ROI Potential - baoquankhu1.vn
Can Leap Therapeutics Inc deliver consistent dividendsMarket Activity Report & Capital Protection Trade Alerts - baoquankhu1.vn
Aug Chart Watch: Can Leap Therapeutics Inc withstand a market correction2025 Institutional Moves & Daily Market Momentum Tracking - baoquankhu1.vn
Momentum Shift: Whats the beta of Leap Therapeutics Inc stockQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
Big Money Moves: Is Sohucom Limited Depositary Receipt exposed to currency risksWeekly Gains Report & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Can Leap Therapeutics Inc. deliver consistent dividendsStop Loss & AI Based Trade Execution Alerts - mfd.ru
Can Leap Therapeutics Inc. stock beat market expectations this quarterRecession Risk & AI Driven Stock Price Forecasts - mfd.ru
Can Leap Therapeutics Inc. (5MC) stock stage a strong rebound this quarterJuly 2025 Gainers & Precise Swing Trade Entry Alerts - mfd.ru
Weekly Recap: Is Leap Therapeutics Inc a top pick in the sectorPortfolio Return Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Can Leap Therapeutics Inc withstand a market correctionJuly 2025 News Drivers & Technical Buy Zone Confirmation - baoquankhu1.vn
EV Market: Will Leap Therapeutics Inc outperform tech stocksMarket Risk Analysis & Accurate Intraday Trade Tips - baoquankhu1.vn
Leap Therapeutics (NASDAQ:LPTX) versus Cyclacel Pharmaceuticals (NASDAQ:BGMS) Financial Contrast - Defense World
Pharma News: Is Altisource Portfolio Solutions SA Equity Warrant being accumulated by smart moneyStop Loss & Safe Entry Trade Reports - baoquankhu1.vn
Leap Therapeutics Stock More Than Doubles On Zcash Treasury Pivot – Former POTUS Advisor Calls It ‘Gangster’ Move - MSN
Analyzing Leap Therapeutics (NASDAQ:LPTX) and Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Earnings Beat: Can Leap Therapeutics Inc stock outperform in a bear market2025 Volatility Report & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Exit Recap: Should I average down on PodcastOne Inc stockGap Down & Smart Investment Allocation Insights - baoquankhu1.vn
Published on: 2026-01-18 21:43:08 - baoquankhu1.vn
Critical Review: Pharmaxis (OTCMKTS:PXSLY) vs. Leap Therapeutics (NASDAQ:LPTX) - Defense World
Leap Therapeutics Is Going Wild: Is LPTX The Next Biotech Moonshot Or Just Hype? - AD HOC NEWS
Stock Recap: Can Leap Therapeutics Inc ride the EV waveEarnings Overview Report & High Yield Equity Trading Tips - baoquankhu1.vn
Can Leap Therapeutics Inc disrupt its industry2025 Momentum Check & Community Shared Stock Ideas - baoquankhu1.vn
US Market Wrap: How Leap Therapeutics Inc stock compares to growth peers2025 Market Overview & Verified Momentum Stock Alerts - Bộ Nội Vụ
Institution Moves: Is Leap Therapeutics Inc. stock near bottom after declineWeekly Trade Review & Reliable Entry Point Alerts - Bộ Nội Vụ
How Leap Therapeutics Inc. stock performs after earningsTrail vs Road Selection & HOKA model picks for your routine - Улправда
How Leap Therapeutics Inc. stock reacts to bond yieldsWeekly Market Outlook & Community Trade Idea Sharing - Улправда
How Leap Therapeutics Inc. stock reacts to job market dataNew Guidance & Expert Verified Stock Movement Alerts - ulpravda.ru
Can Leap Therapeutics Inc. stock maintain operating marginsJuly 2025 Levels & Precise Swing Trade Alerts - ulpravda.ru
CEO Moves: Will Leap Therapeutics Inc stock split attract more investorsDollar Strength & AI Driven Price Predictions - moha.gov.vn
Gainers Report: Will Leap Therapeutics Inc stock split attract more investorsProduct Launch & AI Based Buy and Sell Signals - moha.gov.vn
Reviewing Leap Therapeutics (NASDAQ:LPTX) and Vincerx Pharma (NASDAQ:VINC) - Defense World
Published on: 2025-12-26 06:38:32 - moha.gov.vn
Does Leap Therapeutics Inc. stock trade at a discount to peersGlobal Markets & Entry Point Strategy Guides - Улправда
Aug Decliners: Does Leap Therapeutics Inc. stock trade at a discount to peersEarnings Beat & Daily Oversold Stock Bounce Ideas - Улправда
Why Leap Therapeutics Inc. (5MC) stock is favored by hedge fundsQuarterly Investment Review & AI Based Buy and Sell Signals - Улправда
Is Leap Therapeutics Inc. stock near bottom after declineShare Buyback & Consistent Return Investment Signals - Улправда
Will Leap Therapeutics Inc. stock attract ESG investorsTrade Performance Summary & Reliable Entry Point Trade Alerts - Улправда
Why Leap Therapeutics Inc. stock is a must watch in 2025Weekly Profit Summary & Weekly Setup with High ROI Potential - Улправда
Is Leap Therapeutics Inc. stock a bargain at current levelsJuly 2025 Analyst Calls & Low Drawdown Trading Techniques - DonanımHaber
VIX Spike: Does Leap Therapeutics Inc. stock trade at a discount to peersJuly 2025 Price Swings & Daily Momentum Trading Reports - Улправда
Merger Talk: Will Leap Therapeutics Inc. stock attract ESG investorsQuarterly Profit Report & Short-Term High Return Ideas - Улправда
Analyzing PaxMedica (NASDAQ:PXMD) and Leap Therapeutics (NASDAQ:LPTX) - Defense World
Transcript : Leap Therapeutics, Inc.Shareholder/Analyst Call - marketscreener.com
립 테라퓨틱스 (LPTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
립 테라퓨틱스 주식 (LPTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| CAVANAUGH JAMES H | Director |
Nov 17 '25 |
Sale |
3.14 |
261,840 |
822,178 |
0 |
| ONSI DOUGLAS E | CEO,CFO,Pres.,GC,Treas.&Sec. |
Nov 17 '25 |
Sale |
3.14 |
676,319 |
2,123,642 |
2,136 |
0.37%
자본화:
|
볼륨(24시간):